Company Filing History:
Years Active: 2014-2020
Title: **Je Phil Ryoo: Innovator in Antiviral Pharmaceuticals**
Introduction
Je Phil Ryoo, an accomplished inventor located in Princeton, NJ, holds an impressive portfolio of 9 patents. His contributions to the field of pharmaceuticals, particularly in antiviral compositions, have garnered significant attention and paved the way for novel therapeutic options.
Latest Patents
Among his latest innovations is a patent for a topical antiviral composition that contains a local anesthetic. This invention provides a novel pharmaceutical composition and details a method of making it. The composition includes an effective amount of an antiviral agent, such as sorivudine, and a local anesthetic like lidocaine or its pharmaceutically acceptable salt. This advancement aims to address herpes virus infections caused by common strains, including herpes simplex virus types 1 and 2 (HSV1 and HSV2) and varicella-zoster virus (VZV).
Another of his recent patents introduces a new oral dosage form, designed as a biodegradable, water-soluble film. This innovative method allows for the delivery of pharmaceutically active agents by insertion into the mouth, facilitating selective uptake through the mucosa while avoiding the gastrointestinal tract.
Career Highlights
Throughout his career, Je Phil Ryoo has made a significant impact in the pharmaceutical industry. He has worked with reputable organizations, such as Nal Pharmaceuticals and the Nal Pharmaceutical Group Limited, contributing his expertise to develop cutting-edge therapeutic solutions.
Collaborations
Je Phil Ryoo has collaborated with notable colleagues in the field, including Chun Kwong Chu and Zheng Wang. Their teamwork has fostered a dynamic environment for innovation and has further advanced the research in antiviral medications.
Conclusion
Je Phil Ryoo stands out as a prominent inventor whose work addresses critical healthcare challenges. His patented innovations in antiviral compositions and drug delivery systems are paving the way for more effective treatments for herpes virus infections. As the pharmaceutical landscape continues to evolve, his contributions will undoubtedly play a key role in shaping future advancements.